Birgit Cremer

432 total citations
14 papers, 300 citations indexed

About

Birgit Cremer is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Birgit Cremer has authored 14 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Epidemiology and 6 papers in Neurology. Recurrent topics in Birgit Cremer's work include Neuroendocrine Tumor Research Advances (7 papers), Neuroblastoma Research and Treatments (6 papers) and Lung Cancer Research Studies (6 papers). Birgit Cremer is often cited by papers focused on Neuroendocrine Tumor Research Advances (7 papers), Neuroblastoma Research and Treatments (6 papers) and Lung Cancer Research Studies (6 papers). Birgit Cremer collaborates with scholars based in Germany, United Kingdom and Netherlands. Birgit Cremer's co-authors include Michael Hallek, Valentin Goede, Martin R. Weihrauch, Thomas C. Koslowsky, Rainer Schnell, Oliver Coutelle, A. Reinacher-Schick, Margarete Odenthal, Wolff Schmiegel and Hamid Kashkar and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and Annals of Surgical Oncology.

In The Last Decade

Birgit Cremer

14 papers receiving 298 citations

Peers

Birgit Cremer
Lingling Li China
Leandro Jimenez Brazil
Yuichiro Yamamoto Japan
Lu Pan China
Yunfeng Zhang China
Daqian Gu China
Anna Paterson United Kingdom
Ángel Castaño Spain
Jai‐Nien Tung Taiwan
Federico Pio Fabrizio Italy
Lingling Li China
Birgit Cremer
Citations per year, relative to Birgit Cremer Birgit Cremer (= 1×) peers Lingling Li

Countries citing papers authored by Birgit Cremer

Since Specialization
Citations

This map shows the geographic impact of Birgit Cremer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Cremer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Cremer more than expected).

Fields of papers citing papers by Birgit Cremer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Cremer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Cremer. The network helps show where Birgit Cremer may publish in the future.

Co-authorship network of co-authors of Birgit Cremer

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Cremer. A scholar is included among the top collaborators of Birgit Cremer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Cremer. Birgit Cremer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Krogh, Merete, Àlex Teulé, Heinz‐Josef Klümpen, et al.. (2024). 1142O Multivariable analysis of streptozotocin plus 5-fluorouracil and everolimus sequences in advanced pancreatic neuroendocrine tumor patients: The SEQTOR trial (GETNE-1206). Annals of Oncology. 35. S750–S750. 1 indexed citations
3.
Fottner, Christian, Harald Lahner, Henning Jann, et al.. (2022). Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice. Cancers. 14(11). 2718–2718. 5 indexed citations
4.
5.
Fehrenbach, Uli, Antonin Kayser, Ulrich‐Frank Pape, et al.. (2021). Localization Defines Streptozotocin/5-FU Response in Primary Pancreatic Neuroendocrine Tumours. Neuroendocrinology. 112(6). 595–605. 3 indexed citations
6.
Chiapponi, Costanza, Birgit Cremer, Roger Wahba, et al.. (2020). Peptide receptor radionuclide therapy as a two-step strategy for initially unresectable liver disease from neuroendocrine tumors: a single-center experience. Endocrine. 70(1). 187–193. 7 indexed citations
7.
Merola, Elettra, Anja Rinke, Stefano Partelli, et al.. (2019). Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?. Annals of Surgical Oncology. 27(5). 1348–1355. 42 indexed citations
8.
Schmidt, Matthias, Birgid Markiefka, Max Schlaak, et al.. (2012). (68)Ga-DotaTATE PET-CT followed by Peptide Receptor Radiotherapy in combination with capecitabine in two patients with Merkel Cell Carcinoma.. PubMed. 5(4). 363–6. 19 indexed citations
9.
Cremer, Birgit, Brenda M. Sandmaier, Wolfgang Bethge, et al.. (2011). Reduced-Intensity Conditioning in Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Historical Perspective. Onkologie. 34(12). 710–715. 5 indexed citations
10.
Cremer, Birgit, et al.. (2011). Pro-inflammatory effects of ochratoxin A on nasal epithelial cells. European Archives of Oto-Rhino-Laryngology. 269(4). 1155–1161. 17 indexed citations
11.
Vehreschild, Jörg Janne, Maria J. G. T. Vehreschild, Dorothee Arenz, et al.. (2011). Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial. International Journal of Antimicrobial Agents. 39(2). 130–134. 16 indexed citations
12.
Goede, Valentin, Oliver Coutelle, A. Reinacher-Schick, et al.. (2010). Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy. British Journal of Cancer. 103(9). 1407–1414. 142 indexed citations
13.
Hübel, Kai, Birgit Cremer, Eva Heuser, et al.. (2010). A prospective study of serum soluble CD30 in allogeneic hematopoietic stem cell transplantation. Transplant Immunology. 23(4). 215–219. 8 indexed citations
14.
Cremer, Birgit, et al.. (1985). Calciuric response to 1,25-(OH)2D3 in early renal failure.. PubMed. 11(3). 182–5. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lingling Li Breakdown of academic impact, for papers by Leandro Jimenez Breakdown of academic impact, for papers by Yuichiro Yamamoto Breakdown of academic impact, for papers by Lu Pan Breakdown of academic impact, for papers by Yunfeng Zhang Breakdown of academic impact, for papers by Daqian Gu Breakdown of academic impact, for papers by Anna Paterson Breakdown of academic impact, for papers by Ángel Castaño Breakdown of academic impact, for papers by Jai‐Nien Tung Breakdown of academic impact, for papers by Federico Pio Fabrizio
Rankless by CCL
2026